552331-85-8

Basic information

• Product Name: 3-Pyridinethiol, 5-bromo-
• Synonyms: 3-Pyridinethiol, 5-bromo-;5-BroMopyridine-3-thiol
• CAS NO: 552331-85-8
• Molecular Formula: C₅H₄BrNS
• Molecular Weight: 190
• Mol File: 552331-85-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 248.2±25.0 °C(Predicted)
• Appearance: /
• Density: 1.705±0.06 g/cm3(Predicted)
• PKA: 5.40±0.20(Predicted)
• CAS DataBase Reference: 3-Pyridinethiol, 5-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinethiol, 5-bromo-(552331-85-8)
• EPA Substance Registry System: 3-Pyridinethiol, 5-bromo-(552331-85-8)

Safety Data

• Hazardous Substances Data: 552331-85-8(Hazardous Substances Data)

Usage

General Description

3-Pyridinethiol, 5-bromo- is a chemical compound with the formula C5H4BrNS. It is a synthetic precursor used in the production of pharmaceuticals and agrochemicals. 3-Pyridinethiol, 5-bromo- is known for its applications in organic synthesis, particularly in the creation of heterocyclic compounds. It is also used as a building block for the synthesis of various functional molecules. 3-Pyridinethiol, 5-bromo- has potential applications in the development of new materials and drugs due to its unique chemical properties and reactivity.

Upstream product

• 74115-13-2 5-bromopyridine-3-ol 

Downstream Products

• 1415474-11-1 5-(1-benzyl-6-chloro-2-methyl-1H-indol-3-ylsulfanyl)-nicotinic acid 
• 1415474-31-5 5-[6-chloro-2-methyl-1-(1-methyl-1H-pyrazol-4-yl)-1H-indol-3-ylsulfanyl]-nicotinic acid methyl ester 

Relevant articles and documents

ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS

The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human.

ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS

The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns compounds for use in a method of treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.